22 December 2025
Hogan Lovells advises Recordati on the agreements for the acquisition of the manufacturing and commercialization rights to Inrebic® in Japan
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Francesco Stella Lead | Hogan Lovells Cadwalader | Partner | Not stated | Not stated |
| Penny Powell Lead | Hogan Lovells Cadwalader | Partner | Not stated | Not stated |
| Bea Watts | Hogan Lovells Cadwalader | Associate | Not stated | London |
| James Furneaux | Hogan Lovells Cadwalader | Associate | Not stated | London |
| Frederick Ch'en | Hogan Lovells Cadwalader | Partner | Not stated | Tokyo |
| Hiroto Imai | Hogan Lovells Cadwalader | Partner | Not stated | Tokyo |
| Audrey Haroz Reed | Hogan Lovells Cadwalader | Partner | Not stated | Washington |
| Cullen Taylor | Hogan Lovells Cadwalader | Partner | Not stated | Washington |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- RecordatiBuy-side
- Counterparties
- Impact Biomedicines (Sell-side)